Details for New Drug Application (NDA): 084850
✉ Email this page to a colleague
NDA 084850 describes MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN, which is a drug marketed by Belmora Llc and is included in one NDA. Additional details are available on the MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN profile page.
The generic ingredient in MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
The generic ingredient in MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.
Summary for 084850
| Tradename: | MEPIVACAINE HYDROCHLORIDE W/ LEVONORDEFRIN |
| Applicant: | Belmora Llc |
| Ingredient: | levonordefrin; mepivacaine hydrochloride |
| Patents: | 0 |
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.05MG/ML;2% | ||||
| Approval Date: | Oct 21, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
